Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM)
✍ Scribed by Niles Fox; James Schrementi; Masahiro Nishi; Shinyo Ohagi; Shu Jin Chan; Judith A Heisserman; Gunilla T. Westermark; Arnold Leckström; Per Westermark; Donald F. Steiner
- Book ID
- 115928485
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 780 KB
- Volume
- 323
- Category
- Article
- ISSN
- 0014-5793
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Type 2 (non-insulin-dependent) diabetes is associated with the deposition of islet amyloid. The major formative peptide, islet amyloid polypeptide, has recently been characterised and an abnormality of the structure or expression of this gene is a possible candidate for the inherited component of Ty
Marchione, C.S., and R.W. Tuman: Linogliride fumarate, an oral hypoglycemic agent, improves oral glucose tolerance in a rat model of non-insulin-dependent diabetes mellitus (NIDDM). Drug Dev. Res. 17:161-168, 1989. Linogliride fumarate, a structurally novel oral hypoglycemic compound, was tested in
An increased prevalence of Type 1 (insulin-dependent) diabetes has been reported in patients with congenital rubella. Rubella virus multiplies in the pancreas, and we have hypothesized that studies of children with congenital rubella would be of great importance in following the development of Type